BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $9,291,000 | -51.8% | 130,900 | -6.4% | 2.10% | -51.2% |
Q4 2021 | $19,282,000 | -21.3% | 139,900 | -20.7% | 4.30% | -27.3% |
Q3 2021 | $24,490,000 | +43.1% | 176,400 | 0.0% | 5.91% | +30.7% |
Q2 2021 | $17,113,000 | +41.9% | 176,400 | 0.0% | 4.52% | +41.7% |
Q1 2021 | $12,057,000 | -29.8% | 176,400 | -12.0% | 3.19% | -32.0% |
Q4 2020 | $17,178,000 | +92.3% | 200,400 | +45.9% | 4.69% | +62.7% |
Q3 2020 | $8,931,000 | +186.3% | 137,400 | +205.3% | 2.88% | +178.0% |
Q2 2020 | $3,119,000 | +39.8% | 45,000 | -11.7% | 1.04% | +25.4% |
Q2 2019 | $2,231,000 | +44.5% | 50,949 | +69.8% | 0.83% | +45.1% |
Q1 2019 | $1,544,000 | – | 30,000 | – | 0.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |